AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 14696004 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Cholangiopancreatography (MRCP)
Number of subjects: 10
Study 14696004 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic Retrograde Cholangiopancreatography (ERCP)
Number of subjects: 10
Study 10686224 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal misoprostol 400 microg every 3 h for a maximum of five doses in 24 h
Number of subjects: 148
Study 10686224 — intervention group
Group type: COMPARATOR
Intervention: Vaginal misoprostol 400 microg every 6 h for a maximum of three doses in 24 h
Number of subjects: 148
Study 9349857 — intervention group
Group type: EXPERIMENTAL
Intervention: 16 mg betahistine
Number of subjects: 12
Study 9349857 — intervention group
Group type: EXPERIMENTAL
Intervention: 32 mg betahistine
Number of subjects: 12
Study 9349857 — intervention group
Group type: EXPERIMENTAL
Intervention: 64 mg betahistine
Number of subjects: 12
Study 9349857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 7997605 — intervention group
Group type: EXPERIMENTAL
Intervention: Color-Doppler US
Number of subjects: 29
Study 7997605 — intervention group
Group type: EXPERIMENTAL
Intervention: Local treatment
Number of subjects: 29
Study 2899660 — intervention group
Group type: EXPERIMENTAL
Intervention: azathioprine 2.5 mg/kg daily
Number of subjects: 354
Study 2899660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 354
Study 31980883 — intervention group
Group type: COMPARATOR
Intervention: Voice therapy and medicament therapy (group 1)
Number of subjects: 149
Study 31980883 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice therapy, medicament therapy, and transcutaneous electrical stimulation (group 2)
Number of subjects: 149
Study 30133685 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquanet EC‐2000®
Number of subjects: 200
Study 30133685 — intervention group
Group type: COMPARATOR
Intervention: Mannitol solution
Number of subjects: 200
Study 27305912 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 1500 mg PO daily
Number of subjects: 35
Study 27305912 — intervention group
Group type: COMPARATOR
Intervention: Untreated historical controls
Number of subjects: 35
Study 26549714 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate 120 mg
Number of subjects: 110
Study 26549714 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide mononitrate (all doses)
Number of subjects: 110
Study 26549714 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 24419872 — intervention group
Group type: EXPERIMENTAL
Intervention: Inner speech
Number of subjects: 29
Study 24419872 — intervention group
Group type: EXPERIMENTAL
Intervention: Heard speech
Number of subjects: 29
Study 24419872 — intervention group
Group type: EXPERIMENTAL
Intervention: Different verse types (hexameter and alliteration)
Number of subjects: 29
Study 22409340 — intervention group
Group type: EXPERIMENTAL
Intervention: rTMS
Number of subjects: 11
Study 22409340 — intervention group
Group type: COMPARATOR
Intervention: Sham TMS
Number of subjects: 11
Study 20136764 — intervention group
Group type: EXPERIMENTAL
Intervention: Football training (F)
Number of subjects: 47
Study 20136764 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 47
Study 20136764 — intervention group
Group type: EXPERIMENTAL
Intervention: Running training (R)
Number of subjects: 47
Study 18361658 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative recall with spouses
Number of subjects: 2
Study 18361658 — intervention group
Group type: COMPARATOR
Intervention: Nominal groups (spouses remembering alone)
Number of subjects: 2
Study 18361658 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative recall
Number of subjects: 2
Study 16204903 — intervention group
Group type: COMPARATOR
Intervention: 5% lignocaine
Number of subjects: 90
Study 16204903 — intervention group
Group type: COMPARATOR
Intervention: 0.5% minoxidil
Number of subjects: 90
Study 16204903 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 5% lignocaine and 0.5% minoxidil
Number of subjects: 90
Study 16204903 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 90
Study 12432838 — intervention group
Group type: COMPARATOR
Intervention: Presence of anti‐Helicobacter pylori antibodies (anti‐HP Ab) in women with vomiting (162 women)
Number of subjects: 3438
Study 12432838 — intervention group
Group type: COMPARATOR
Intervention: Presence of anti‐Helicobacter pylori antibodies (anti‐HP Ab) in women with severe emesis (250 women)
Number of subjects: 3438
Study 10707114 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen with diazepam administered at 22.00 hours
Number of subjects: 8
Study 10707114 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen alone administered at 22.00 hours
Number of subjects: 8
Study 9167559 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmeterol 50 micrograms twice daily
Number of subjects: 101
Study 9167559 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 8466725 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine (2.5 mg twice daily)
Number of subjects: 143
Study 8466725 — intervention group
Group type: COMPARATOR
Intervention: Felodipine (2.5 mg twice daily)
Number of subjects: 143
Study 8466725 — intervention group
Group type: EXPERIMENTAL
Intervention: Isradipine
Number of subjects: 143
Study 2869027 — intervention group
Group type: EXPERIMENTAL
Intervention: trihexyphenidyl (N = 15)
Number of subjects: 42
Study 2869027 — intervention group
Group type: COMPARATOR
Intervention: placebo (N = 27)
Number of subjects: 42
Study 30452665 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face F-PST
Number of subjects: 150
Study 30452665 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-guided online F-PST
Number of subjects: 150
Study 30452665 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-guided online F-PST
Number of subjects: 150
Study 30452665 — intervention group
Group type: COMPARATOR
Intervention: Therapist-involved approaches (face-to-face and therapist-guided online)
Number of subjects: 150
Study 30452665 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 150
Study 29964324 — intervention group
Group type: COMPARATOR
Intervention: D2 laparoscopic distal gastrectomy
Number of subjects: 161
Study 29964324 — intervention group
Group type: EXPERIMENTAL
Intervention: D2+ CME laparoscopic distal gastrectomy
Number of subjects: 161
Study 27893068 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of the 9-valent HPV vaccine (6 months apart)
Number of subjects: 1518
Study 27893068 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 doses of the 9-valent HPV vaccine (12 months apart)
Number of subjects: 1518
Study 27893068 — intervention group
Group type: COMPARATOR
Intervention: 3 doses of the 9-valent HPV vaccine (6 months apart)
Number of subjects: 1518
Study 24170263 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib 400 mg p.o. alone
Number of subjects: 11
Study 24170263 — intervention group
Group type: COMPARATOR
Intervention: Imatinib 400 mg p.o. with 4,000 mg calcium carbonate (Tums Ultra) administered 15 min before
Number of subjects: 11
Study 23164965 — intervention group
Group type: EXPERIMENTAL
Intervention: Corpitolinol 60
Number of subjects: 301
Study 23164965 — intervention group
Group type: COMPARATOR
Intervention: Control (usual measures for preventing pressure sores)
Number of subjects: 301
Study 20051731 — intervention group
Group type: EXPERIMENTAL
Intervention: One-leg cycling (OLC) aerobic training program with the untreated leg plus a rehabilitation program (training group, TG)
Number of subjects: 24
Study 20051731 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation program without aerobic training (control group, CG)
Number of subjects: 24
Study 19192865 — intervention group
Group type: EXPERIMENTAL
Intervention: Prize contingency management for smoking cessation (n=12)
Number of subjects: 24
Study 19192865 — intervention group
Group type: COMPARATOR
Intervention: Standard care for smoking cessation (n=12)
Number of subjects: 24
Study 15793663 — intervention group
Group type: EXPERIMENTAL
Intervention: MCH-3' (3-minute interval methacholine challenge test)
Number of subjects: 52
Study 15793663 — intervention group
Group type: EXPERIMENTAL
Intervention: MCH-5' (5-minute interval methacholine challenge test)
Number of subjects: 52
Study 15793663 — intervention group
Group type: COMPARATOR
Intervention: MCH-3' and MCH-5'
Number of subjects: 52
Study 12453124 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite (HA) coating
Number of subjects: 313
Study 12453124 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium plasma-flame (TPF) coating
Number of subjects: 313
Study 12453124 — intervention group
Group type: COMPARATOR
Intervention: Both coatings (HA and TPF)
Number of subjects: 313
Study 9841760 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEPO) 300 IU/kg on day 4 before surgery and 150 IU/kg daily for 7 days
Number of subjects: 81
Study 9841760 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 81
Study 9841760 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human erythropoietin (r‐HuEPO)
Number of subjects: 81
Study 7783099 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine
Number of subjects: 25
Study 7783099 — intervention group
Group type: COMPARATOR
Intervention: Diuretic
Number of subjects: 25
Study 8404359 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol and indomethacin
Number of subjects: 40
Study 2860179 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine (PVP-I)
Number of subjects: 0
Study 2860179 — intervention group
Group type: COMPARATOR
Intervention: 60% n-propanol
Number of subjects: 0
Study 30057060 — intervention group
Group type: EXPERIMENTAL
Intervention: Chamomile essence (aromatherapy)
Number of subjects: 130
Study 30057060 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chamomile essence)
Number of subjects: 130
Study 27776598 — intervention group
Group type: EXPERIMENTAL
Intervention: Endobronchial valve (EbV) treatment
Number of subjects: 102
Study 27776598 — intervention group
Group type: COMPARATOR
Intervention: Complex second-line treatment (control)
Number of subjects: 102
Study 24317232 — intervention group
Group type: EXPERIMENTAL
Intervention: SPEDI technique (15 mL of ropivacaine 0.75% around the sciatic nerve and 5 mL of ropivacaine 0.75% at the saphenous nerve)
Number of subjects: 60
Study 24317232 — intervention group
Group type: COMPARATOR
Intervention: Popliteal-sciatic/saphenous technique
Number of subjects: 60
Study 21939399 — intervention group
Group type: EXPERIMENTAL
Intervention: Training tasks performed with the non-dominant hand for three weeks
Number of subjects: 26
Study 21939399 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific training tasks)
Number of subjects: 26
Study 20421242 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRA Standard of Care program (additional counseling and clinical care)
Number of subjects: 323
Study 20421242 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRA Standard of Care program (referrals to government healthcare facilities)
Number of subjects: 323
Study 20421242 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRA Standard of Care program (enrollment in wellness/treatment programs)
Number of subjects: 323
Study 20421242 — intervention group
Group type: EXPERIMENTAL
Intervention: MIRA Standard of Care program (declined further care)
Number of subjects: 323
Study 18572029 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg/day
Number of subjects: 30
Study 18572029 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 30
Study 16051910 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumer-directed care (treatment group)
Number of subjects: 1433
Study 16051910 — intervention group
Group type: COMPARATOR
Intervention: Traditional agency services (control group)
Number of subjects: 1433
Study 12132030 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioseal
Number of subjects: 851
Study 12132030 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoseal
Number of subjects: 851
Study 12132030 — intervention group
Group type: EXPERIMENTAL
Intervention: Duett
Number of subjects: 851
Study 12132030 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioseal, Vasoseal, Duett
Number of subjects: 851
Study 10599715 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 106
Study 7551613 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined live+imagined exposure/ritual prevention (Exi)
Number of subjects: 46
Study 7551613 — intervention group
Group type: COMPARATOR
Intervention: Only live exposure/ritual prevention (Ex)
Number of subjects: 46
Study 1791078 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g cefotaxime i.v. plus 200 mg ofloxacin twice daily (group 1)
Number of subjects: 87
Study 1791078 — intervention group
Group type: COMPARATOR
Intervention: 2 g cefotaxime i.v. twice daily plus tobramycin i.v. three times daily (group 2)
Number of subjects: 87
Study 6969937 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical neurostimulation (TENS)
Number of subjects: 0
Study 30805617 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver sulfadiazine (SSD) dressing
Number of subjects: 60
Study 30805617 — intervention group
Group type: EXPERIMENTAL
Intervention: Polylactic membrane (PLM) dressing
Number of subjects: 60
Study 30805617 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrofiber with silver (HFAg) dressing
Number of subjects: 60
Study 30805617 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 28688822 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing high-calorie food pictures
Number of subjects: 40
Study 26378939 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient empowerment through information booklet and diary keeping
Number of subjects: 652
Study 26378939 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 652
Study 23361056 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate cancer screening preferences
Number of subjects: 1000
Study 21350928 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.12 mg/70 kg) + Progesterone (100 mg)
Number of subjects: 11
Study 21350928 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam (0.25 mg/70 kg) + Progesterone (200 mg)
Number of subjects: 11
Study 21350928 — intervention group
Group type: COMPARATOR
Intervention: Triazolam alone
Number of subjects: 11
Study 21350928 — intervention group
Group type: EXPERIMENTAL
Intervention: Progesterone alone (100 mg and 200 mg)
Number of subjects: 11
Study 19628958 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual narrative exposure therapy (NET, n=12)
Number of subjects: 26
Study 19628958 — intervention group
Group type: COMPARATOR
Intervention: Group adaptation of interpersonal psychotherapy (IPT, n=14)
Number of subjects: 26
Study 17374660 — intervention group
Group type: EXPERIMENTAL
Intervention: LTP-enriched yogurt beverage
Number of subjects: 6
Study 17374660 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 15098169 — intervention group
Group type: EXPERIMENTAL
Intervention: TCI-TIVA
Number of subjects: 51
Study 15098169 — intervention group
Group type: EXPERIMENTAL
Intervention: MAN-TIVA
Number of subjects: 51
Study 15098169 — intervention group
Group type: EXPERIMENTAL
Intervention: BAL-SEVO
Number of subjects: 51
Study 11216756 — intervention group
Group type: EXPERIMENTAL
Intervention: Antegrade crystalloid cardioplegia (group A, n = 29)
Number of subjects: 58
Study 11216756 — intervention group
Group type: EXPERIMENTAL
Intervention: Retrograde crystalloid cardioplegia (group R, n = 29)
Number of subjects: 58
Study 9798655 — intervention group
Group type: EXPERIMENTAL
Intervention: IST plus recombinant human erythropoietin and granulocyte‐macrophage colony‐stimulating factor (rhEPO + rhGM‐CSF)
Number of subjects: 38
Study 9798655 — intervention group
Group type: COMPARATOR
Intervention: IST alone
Number of subjects: 38
Study 9798655 — intervention group
Group type: EXPERIMENTAL
Intervention: ALG plus HGFs
Number of subjects: 38
Study 7886971 — intervention group
Group type: EXPERIMENTAL
Intervention: molsidomin (2 mg)
Number of subjects: 10
Study 7886971 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (8 mg)
Number of subjects: 10
Study 7886971 — intervention group
Group type: EXPERIMENTAL
Intervention: molsidomin (2 mg) and ondansetron (8 mg)
Number of subjects: 10
Study 2974775 — intervention group
Group type: EXPERIMENTAL
Intervention: Humulin‐Zn
Number of subjects: 22
Study 2974775 — intervention group
Group type: EXPERIMENTAL
Intervention: Neulente insulin
Number of subjects: 22
Study 2974775 — intervention group
Group type: COMPARATOR
Intervention: Non-insulin treated patients
Number of subjects: 22
Study 29626313 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressed mood state induction in asthma group
Number of subjects: 84
Study 29626313 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral mood state induction in asthma group
Number of subjects: 84
Study 29626313 — intervention group
Group type: COMPARATOR
Intervention: Depressed mood state induction in healthy controls
Number of subjects: 84
Study 29626313 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood state induction in healthy controls
Number of subjects: 84
Study 28237955 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led facilitated advance care planning intervention
Number of subjects: 149
Study 28237955 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 149
Study 26188380 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive Cognitive Therapy (PCT)
Number of subjects: 172
Study 26188380 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 172
Study 22930656 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-help treatment (Deprexis)
Number of subjects: 210
Study 22930656 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 210
Study 20386359 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene-based dosing algorithm
Number of subjects: 229
Study 20386359 — intervention group
Group type: COMPARATOR
Intervention: Standard of care dosing
Number of subjects: 229
Study 18179471 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive dental services in medical offices
Number of subjects: 744
Study 18179471 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline preventive dental visit at a younger age
Number of subjects: 744
Study 18179471 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregivers reporting greater numbers of children and putting the child to bed with the bottle
Number of subjects: 744
Study 18179471 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age of child, male child, caregiver education ≤ 12 years
Number of subjects: 744
Study 16617916 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal scopolamine
Number of subjects: 56
Study 16617916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study 14763702 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily pin site care (n = 27)
Number of subjects: 50
Study 14763702 — intervention group
Group type: COMPARATOR
Intervention: Weekly pin site care (n = 23)
Number of subjects: 50
Study 10808698 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum CYFRA 21-1
Number of subjects: 51
Study 10808698 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum CEA
Number of subjects: 51
Study 10808698 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of CYFRA 21-1 and CEA
Number of subjects: 51
Study 10808698 — intervention group
Group type: COMPARATOR
Intervention: Patients with benign lung diseases
Number of subjects: 51
Study 8848646 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified supraclavicular technique (group 2)
Number of subjects: 100
Study 8848646 — intervention group
Group type: COMPARATOR
Intervention: Axillary perivascular technique (group 1)
Number of subjects: 100
Study 1599986 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diazepam (0.1 mg/kg)
Number of subjects: 6
Study 1599986 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 6
Study 4040421 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 100
Study 4040421 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin
Number of subjects: 100
Study 31387013 — intervention group
Group type: EXPERIMENTAL
Intervention: Shame condition
Number of subjects: 88
Study 31387013 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 88
Study 31387013 — intervention group
Group type: EXPERIMENTAL
Intervention: Both conditions
Number of subjects: 88
Study 30043415 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy during hospitalisation (twice a week for four to six weeks)
Number of subjects: 29
Study 30043415 — intervention group
Group type: COMPARATOR
Intervention: Control group received no music therapy during hospitalisation, intervention after discharge
Number of subjects: 29
Study 26645391 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (BI) by trained general practitioners
Number of subjects: 60
Study 26645391 — intervention group
Group type: COMPARATOR
Intervention: Business as usual (BAU)
Number of subjects: 60
Study 24825078 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (45 mg, single oral dose)
Number of subjects: 24
Study 24825078 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medication)
Number of subjects: 24
Study 21788248 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic field therapy
Number of subjects: 50
Study 21788248 — intervention group
Group type: COMPARATOR
Intervention: Sham therapy
Number of subjects: 50
Study 20456191 — intervention group
Group type: EXPERIMENTAL
Intervention: Menthol 10% solution
Number of subjects: 35
Study 20456191 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.5% ethanol solution of menthol)
Number of subjects: 35
Study 17062582 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist group (n=148)
Number of subjects: 299
Study 17062582 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=151)
Number of subjects: 299
Study 15748121 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic post-stroke subjects
Number of subjects: 21
Study 15748121 — intervention group
Group type: COMPARATOR
Intervention: Healthy age-matched control subjects
Number of subjects: 21